S.L. Schreiber

2.8k total citations · 1 hit paper
19 papers, 2.1k citations indexed

About

S.L. Schreiber is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, S.L. Schreiber has authored 19 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Immunology and 8 papers in Oncology. Recurrent topics in S.L. Schreiber's work include Signaling Pathways in Disease (15 papers), Peptidase Inhibition and Analysis (8 papers) and Toxin Mechanisms and Immunotoxins (6 papers). S.L. Schreiber is often cited by papers focused on Signaling Pathways in Disease (15 papers), Peptidase Inhibition and Analysis (8 papers) and Toxin Mechanisms and Immunotoxins (6 papers). S.L. Schreiber collaborates with scholars based in United States. S.L. Schreiber's co-authors include Eric J. Brown, Robert F. Standaert, Xiao-Feng Zheng, Jie Chen, Barbara E. Bierer, Gerald R. Crabtree, Petri S. Mattila, L A Herzenberg, Steven J. Burakoff and S Luan and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

S.L. Schreiber

19 papers receiving 2.1k citations

Hit Papers

Two distinct signal transmission pathways in T lymphocyte... 1990 2026 2002 2014 1990 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.L. Schreiber United States 15 1.7k 463 420 244 164 19 2.1k
Stuart L. Schreiber United States 12 2.3k 1.4× 615 1.3× 638 1.5× 64 0.3× 320 2.0× 12 2.7k
Nina Dathan Italy 28 2.8k 1.7× 166 0.4× 436 1.0× 161 0.7× 140 0.9× 48 3.6k
Kumkum Saxena United States 10 1.4k 0.9× 287 0.6× 230 0.5× 227 0.9× 123 0.8× 16 2.2k
J A Barbosa United States 21 1.4k 0.8× 590 1.3× 297 0.7× 74 0.3× 106 0.6× 30 2.4k
Ian G. Cowell United Kingdom 29 2.7k 1.6× 215 0.5× 778 1.9× 300 1.2× 157 1.0× 65 3.2k
Robert A. Aldape United States 12 1.7k 1.0× 535 1.2× 370 0.9× 51 0.2× 77 0.5× 13 2.3k
Horst Ahorn Austria 26 1.6k 0.9× 262 0.6× 240 0.6× 185 0.8× 45 0.3× 37 2.5k
Jeffrey K. Tong United States 11 2.4k 1.5× 136 0.3× 303 0.7× 232 1.0× 100 0.6× 15 2.7k
John P.H. Th'ng Canada 26 2.6k 1.5× 229 0.5× 694 1.7× 236 1.0× 89 0.5× 48 3.1k
Xiang-Jiao Yang Canada 24 3.8k 2.3× 245 0.5× 621 1.5× 202 0.8× 61 0.4× 32 4.2k

Countries citing papers authored by S.L. Schreiber

Since Specialization
Citations

This map shows the geographic impact of S.L. Schreiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.L. Schreiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.L. Schreiber more than expected).

Fields of papers citing papers by S.L. Schreiber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.L. Schreiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.L. Schreiber. The network helps show where S.L. Schreiber may publish in the future.

Co-authorship network of co-authors of S.L. Schreiber

This figure shows the co-authorship network connecting the top 25 collaborators of S.L. Schreiber. A scholar is included among the top collaborators of S.L. Schreiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.L. Schreiber. S.L. Schreiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Liang, Jun, S. E. Ealick, Carsten M. Nielsen, S.L. Schreiber, & Jon Clardy. (1996). Crystallization and preliminary X-ray analysis of twinned crystals of a chimeric FK506 binding protein 12 and 13 complexed with FK506. Acta Crystallographica Section D Biological Crystallography. 52(1). 207–210. 2 indexed citations
2.
Crews, Craig M., W S Lane, & S.L. Schreiber. (1996). Didemnin binds to the protein palmitoyl thioesterase responsible for infantile neuronal ceroid lipofuscinosis.. Proceedings of the National Academy of Sciences. 93(9). 4316–4319. 43 indexed citations
3.
Luan, S, Jörg Kudla, Wilhelm Gruissem, & S.L. Schreiber. (1996). Molecular characterization of a FKBP-type immunophilin from higher plants.. Proceedings of the National Academy of Sciences. 93(14). 6964–6969. 69 indexed citations
4.
Weiss, Gregory A., Edward Collins, David N. Garboczi, et al.. (1996). Covalent HLA-B27/peptide complex induced by specific recognition of an aziridine mimic of arginine.. Proceedings of the National Academy of Sciences. 93(20). 10945–10948. 24 indexed citations
5.
Chen, Jie, Xiao-Feng Zheng, Eric J. Brown, & S.L. Schreiber. (1995). Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue.. Proceedings of the National Academy of Sciences. 92(11). 4947–4951. 433 indexed citations
6.
Li, Wanyu, Sheng Luan, S.L. Schreiber, & Sarah M. Assmann. (1994). Cyclic AMP Stimulates K+ Channel Activity in Mesophyll Cells of Vicia faba L. PLANT PHYSIOLOGY. 106(3). 957–961. 62 indexed citations
7.
Luan, S, W S Lane, & S.L. Schreiber. (1994). pCyP B: a chloroplast-localized, heat shock-responsive cyclophilin from fava bean.. The Plant Cell. 6(6). 885–892. 75 indexed citations
8.
Crews, Craig M., et al.. (1994). GTP-dependent binding of the antiproliferative agent didemnin to elongation factor 1 alpha.. Journal of Biological Chemistry. 269(22). 15411–15414. 111 indexed citations
9.
Albers, Mark W., et al.. (1993). FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line.. Journal of Biological Chemistry. 268(30). 22825–22829. 128 indexed citations
10.
Smith, David F., Mark W. Albers, S.L. Schreiber, Karen L. Leach, & Martin R. Deibel. (1993). FKBP54, a novel FK506-binding protein in avian progesterone receptor complexes and HeLa extracts.. Journal of Biological Chemistry. 268(32). 24270–24273. 66 indexed citations
11.
Lyson, T, et al.. (1993). Cyclosporine- and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling.. Circulation Research. 73(3). 596–602. 78 indexed citations
12.
Luan, S, et al.. (1993). Immunosuppressants implicate protein phosphatase regulation of K+ channels in guard cells.. Proceedings of the National Academy of Sciences. 90(6). 2202–2206. 207 indexed citations
13.
14.
Porter, K. A. & S.L. Schreiber. (1992). INBIBITION OF LIVER, KIDNEY, AND INTESTINE REGENERATION BY RAPAMYCIN. Transplantation. 53(2). 496–498. 34 indexed citations
15.
Stankovic, Charles J. & S.L. Schreiber. (1991). ChemInform Abstract: Molecular Design of Transmembrane Ion Channels. ChemInform. 22(32). 3 indexed citations
16.
Schreiber, S.L.. (1991). ChemInform Abstract: Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands. ChemInform. 22(16). 1 indexed citations
17.
Silberman, Sandra, Yvonne Rosenstein, David C. Diamond, et al.. (1991). The interaction of CD4 with HIV-1 gp120.. PubMed. 3(3). 187–92. 6 indexed citations
18.
Bierer, Barbara E., Petri S. Mattila, Robert F. Standaert, et al.. (1990). Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.. Proceedings of the National Academy of Sciences. 87(23). 9231–9235. 585 indexed citations breakdown →
19.
Standaert, Robert F., et al.. (1990). Inhibition of FKBP Rotamase Activity by Immunosuppressant FK506: Twisted Amide Surrogate. Science. 248(4957). 863–866. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026